DSM enters exclusive talks to buy Cargill’s cultures unit20 September 2012Dutch vitamin giant Royal DSM has confirmed that it is in exclusive talks to acquire Cargill’s €45 million turnover cultures and enzymes business. A deal would be DSM’s nutrition unit’s eighth since the company embarked on a transformation from being commodity-chemical manufacturer to a producer of nutritional supplements, enzymes and speciality plastics in 2010. Growing at around 5% a year, the global cultures and enzymes market is annually worth €1 billion. “A possible combination of the Cargill cultures and enzymes business with the dairy business of DSM Food Specialties would be highly complementary, creating a strong global player,” said the firm in a statement. Meanwhile, DSM has announced the appointment of Chris Goppelsroeder as the firm’s new chief executive for nutritional products. Goppelsroeder, who will succeed Leendert Staal in January, will report to board member Stephan Tanda. Goppelsroeder was a member of the Managing Board of DSM from 2005 to 2006, prior to joining agri-business Syngenta. | |
 Exhibitions Fi Europe | Hi/Ni China | Fi India | Fi Asia | Fi South America | Health ingredients Europe, Ni & NuW | Fi Istanbul Languages      
| |
